◀ Anchor ▶ You may remember the’Invossa Incident’ when it was in the limelight as the world’s first arthritis cell treatment, and the fact of manipulating ingredients was revealed. Two court rulings over Invossa came out today. The decision that it was right to revoke the manufacturing and marketing license as a serious defect in’manipulation … Read more
◀ Anchor ▶ Dutch coffee, made by pouring cold water over coffee powder, is popular these days. When I randomly picked and tested Dutch coffees sold online, some products were infested with bacteria. In one product, more than 14,000 times the standard value of bacteria appeared. Reporter Park Jin-ju covered it. ◀ Report ▶ A … Read more
◀ Anchor ▶ Ahead of the AstraZeneca vaccination, which will start in earnest from the end of this month, the Ministry of Food and Drug Safety held a second expert advisory meeting, and added’cautions’ that should be used by 18 years of age or older but cautioned against 65 years of age and recommended permission … Read more
Ministry of Food and Drug Safety AstraZeneca vaccine. Courtesy of AstraZeneca – – On the 31st of this month, the Ministry of Food and Drug Safety will hold the first expert advisory meeting for permission to use the AstraZeneca vaccine, which is expected to be introduced in Korea. In order to obtain permission for use … Read more
![[코로나19] AstraZeneca vaccine, first expert advisory](https://image.ajunews.com/content/image/2021/01/30/20210130112438654186.jpg "[코로나19] AstraZeneca vaccine, first expert advisory")
[사진=로이터·연합뉴스 제공] – – AstraZeneca’s novel coronavirus infection (Corona 19) vaccine will go through the first advisory phase of authorities on the 31st. <!– .ui-widget-header { background: #cf0a2c; border-top: 3px solid #cf0a2c; margin:0; padding:0; border-radius: 0; overflow: hidden; } .ui-widget-content{ background-color:rgba(255,255,255,0.5); } #prismADP{line-height:0;-webkit-box-sizing:content-box;box-sizing:content-box;} – – – – – –> According to industry sources on the … Read more
Occlutech, a private company Announcing today that the US Food and Drug Administration (FDA) has approved the Breakthrough Device designation status for atrial fibrillation devices. Also known as the Atrial Flow Regulator (AFR), it is used in heart failure (HF) patients with normal left ventricular compression (HFpEF) or low-rate left ventricular compression. (HErEF) Heart failure … Read more